Home > News > QinetiQ: A Future Nanotech Investment?
March 24th, 2005
QinetiQ: A Future Nanotech Investment?
Abstract:
While reading a recent report about pSivida, the Australian-based biotechnology company focused on biomedical applications of nanotechnology, I was reminded that QinetiQ, the United Kingdom-based defense laboratory, may go public in late 2005 (QinetiQ owns approximately 11 percent of pSivida). If it does, I would encourage investors of not only pSivida to take notice but investors of Altair and Nanophase as well. The reason is because the IPO would allow the latter investors the opportunity to invest in QinetiQ’s subsidiary, Qinetiq Nanomaterials—which is Europe’s leading manufacturer and supplier of nanopowders—and thus diversify their portfolios.
Source:
NanoNovus
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Profiles
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||